FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to neurology, and deals with the treatment of ischemic stroke. For this purpose the introduction of ubidecarenone by injection, mainly intravenous, is carried out.
EFFECT: introduction of the medication provides the reduction of the zone of brain tissue injury and reduction of neurologic deficiency expression due to the accumulation of ubidecarenone, possessing an expressed neuroprotective action, in brain tissues.
7 cl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION DOSAGE FORM FOR ACUTE STROKE TREATMENT, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2005 |
|
RU2330680C2 |
| MEDICATION FOR TREATING CEREBRAL CIRCULATION DISORDERS AND BRAIN TRAUMAS | 2012 |
|
RU2554502C9 |
| MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
| AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| MEANS FOR TREATING ISCHEMIA OF VASCULAR BRAINS | 2016 |
|
RU2625740C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND USING THEM IN TREATING CEREBROVASCULAR DISORDERS | 2012 |
|
RU2516922C2 |
| SUBSTANCE OF NEUROTROPIC- NEUROREGULATING ACTIVITY | 2006 |
|
RU2329804C2 |
| METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
